Negocios · 16/4/20041 min de lectura
Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.